APTARGROUP INC. overview

AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced their participation at the 43 rd Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2025. Stephan Tanda, President and CEO, will present at 12:45 p.m. Eastern Standard Time. Vanessa Kanu, Executive Vice President and CFO and Gael Touya, President Aptar Pharma, will also be available. A copy of the presentation will be made available on the...

AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that it has been named a World’s Top Companies for Women 2024 by Forbes for the fourth consecutive year (formerly World’s Top Female Friendly Companies). Aptar is ranked 41 out of the 400 companies included on the list by Forbes and their partner Statista . For this ranking companies were evaluated in three categories including employer brand, public...

AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today reported strong operational performance driven by continued growth of the company’s proprietary drug delivery systems and significant sequential improvement in injectables sales as Enterprise Resource Planning (ERP) system implementation effects moderated. Strong sales from prestige and mass fragrance also contributed positively to the results. Reported sales...

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today declared a quarterly cash dividend of $0.41 per share, an almost 8% increase from the previous dividend amount, bringing the new annualized dividend to $1.64 per share. The payment date is August 17, 2023, to stockholders of record as of July 27, 2023. Stephan Tanda, Aptar President and CEO, commented, “In light of our growth momentum,...

AptarGroup, Inc. (NYSE: ATR), today announced with great sadness that Ervin “Erv” J. LeCoque, the first Chief Executive Officer and Chairman of the Board when Aptar became a publicly traded company, has passed away. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230626546153/en/ Photo: Ervin J. LeCoque, First Aptar CEO and Board Chairman as a Publicly Traded Company “Erv will be greatly missed by his colleagues here at Aptar. He...

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today released its 2022 Corporate Sustainability / ESG Report entitled Purpose Takes Shape. Aptar’s 2022 Corporate Sustainability / ESG Report highlights key milestones and global sustainability strategy progress across the Company’s global operations. This press release features multimedia. View the full release here:...

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, was named one of America’s Climate Leaders 2023 by USA Today on its inaugural list of 400 US companies. Aptar is ranked first in its industry sector and 24 th among the companies who achieved the greatest reduction in their core emissions intensity between 2019 and 2021 – that is, Scope 1 and 2 greenhouse gas emissions in relation to revenue. This...

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today announced that Candace Matthews has been elected independent chairperson of the company’s Board of Directors, effective immediately following the company’s 2023 annual meeting of stockholders on May 3, 2023. Candace will succeed George Fotiades, who will remain on the Board of Directors. This press release features multimedia. View the full...